Atypical thymoma (epithelial-rich thymoma, well-differentiated thymic carcinoma, WHO type B3 thymoma): A conundrum
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154459 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Annikka Weissferdt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: aweissferdt@mdanderson.org. Hauptthemen laut MEDLINE: Thymoma, Thymus Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: aweissferdt@mdanderson.org.
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zitieren
APA
Weissferdt, A., & Moran, C. A. (2023). Atypical thymoma (epithelial-rich thymoma, well-differentiated thymic carcinoma, WHO type B3 thymoma): A conundrum. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154459
Vancouver
Weissferdt A, Moran CA. Atypical thymoma (epithelial-rich thymoma, well-differentiated thymic carcinoma, WHO type B3 thymoma): A conundrum. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154459
BibTeX
@article{Weissferdt2023,
author = {Weissferdt, Annikka and Moran, Cesar A},
title = {Atypical thymoma (epithelial-rich thymoma, well-differentiated thymic carcinoma, WHO type B3 thymoma): A conundrum},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154459}
}
EUVIMED